Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,115 | 20,008 | 23,926 | 38,297 | 24,765 |
| Marketable Securities | 24,098 | 24,375 | 17,869 | 5,572 | N/A |
| Receivables | 160 | 145 | 147 | 100 | N/A |
| TOTAL | $38,642 | $44,878 | $42,289 | $44,150 | $24,951 |
| Non-Current Assets | |||||
| PPE Net | 108 | 76 | 83 | 80 | 83 |
| Investments And Advances | 0 | 400 | 6,032 | 9,544 | 0 |
| Other Non-Current Assets | 24 | 24 | 24 | 24 | 24 |
| TOTAL | $132 | $500 | $6,139 | $9,647 | $107 |
| Total Assets | $38,774 | $45,377 | $48,428 | $53,797 | $25,057 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,077 | 507 | 457 | 399 | 380 |
| Accrued Expenses | 1,917 | 2,885 | 1,722 | 1,266 | 958 |
| TOTAL | $2,995 | $3,392 | $2,179 | $1,665 | $1,337 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,995 | $3,392 | $2,179 | $1,665 | $1,337 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,074 | 1,073 | 1,073 | 1,073 | 1,071 |
| Common Shares | 2 | 2 | 2 | 2 | 1 |
| Retained earnings | -93,455 | -86,446 | -81,812 | -75,439 | -71,193 |
| Other shareholders' equity | -38 | -74 | -35 | -51 | -41 |
| TOTAL | $35,780 | $41,985 | $46,249 | $52,132 | $23,720 |
| Total Liabilities And Equity | $38,774 | $45,377 | $48,428 | $53,797 | $25,057 |